Babesiosis in a patient on infliximab for Crohn's disease.
Cullen
Garret
G
Sands
Bruce E
BE
Yajnik
Vijay
V
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D053626:Atovaquone / Q000627:therapeutic use; D017963:Azithromycin / Q000627:therapeutic use; D001404:Babesiosis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D017963:Azithromycin; D000069285:Infliximab; D053626:Atovaquone